Search

You searched for "OME"

2605 results found

Breaking barriers in Uganda: the story of Elaine Mukaaya

1 July 2019 | | ENTA-Auditory Implants, ENTA-Audiology - Adult, ENTA-Audiology - Paediatric, ENTA-ENT, ENTA-Paediatrics
More than 9% of sub-Saharan Africa’s one billion people live with disabling hearing loss, with children having among the highest rates of childhood hearing loss in the world [1]. Sadly, in concordance with the inverse care law – proposed by...

OBITUARY: Peter Rhys Evans (1948–2022)

7 October 2022
On 3 June 2022, we lost a widely recognised and respected ENT/head and neck surgeon, Mr Peter Rhys Evans.

IFOS activities

1 September 2018 | | ENTA-ENT
International collaboration is more important than ever, and we hear from Prof Milan Profant about a collaboration that grew out of the very successful IFOS meeting in Paris in 2017. IFOS has developed a new philosophy regarding how to organise...

2020 Lancet Commission on dementia: a call to action for integrated hearing healthcare

3 March 2021 | | ENTA-Audiology - Adult, ENTA-Audiology - Diagnostic
Dr Georgiou’s summary of the 2020 update to the 2017 Lancet Commission underscores the importance of medical and hearing healthcare professionals working together to tackle the modifiable risk factors that affect individuals throughout their lives, to help delay or even...

The lessons in setting up a community ENT service in the NHS

2 March 2022 | | ENTA-ENT
Sudeb Mandal, a GP with special interest in ENT, talks about the novel approach taken in the community to deliver ENT services in Kent in the UK. The Kent Community ENT service was born with the vision to bring together...

Murder most foul, strange and unnatural

13 November 2019 | | ENTA-ENT
Hamlet, written by William Shakespeare at the very beginning of the 17th century has definite otological interest. The whole play is about young Prince Hamlet’s revenge for his father’s murder. The king is killed by Hamlet’s wicked uncle, who then...

History of ENT - Murder most foul, strange and unnatural

25 June 2019 |
Hamlet written by William Shakespeare at the very beginning of the 17th century has definite otological interest. The whole play is about young Prince Hamlet’s revenge for his father’s murder. The king is killed by Hamlet’s wicked uncle, who then...

Consultation on cochlear implantation guidelines

4 April 2023
A taskforce of 52 hearing experts has released Living Guidelines for hearing care.

Platinum-based chemotherapy, tinnitus and hearing loss

10 March 2023 | | ENTA-Audiology - Adult, ENTA-Tinnitus
Fortunately, the five-year survival rate of adult cancers is increasing. However, we are seeing for the first time the lasting effects of cancer treatments on people. As more people live with the long-term effects of treatment, such as chemotherapy, it is imperative to understand the impact it has on quality of life.

FDA Approved Lenire Expands Number of US Clinics

1 March 2024 | Company Profiles, Contracts & Distributors, Research & Development
Neuromod Devices, the medical technology company that developed tinnitus treatment device, Lenire, has partnered with an additional 24 new US clinics to address the significant demand for the FDA Approved tinnitus treatment device.

The Laryngeal Pacemaker – developing an innovative solution for bilateral vocal fold paralysis

4 July 2024 | | ENTA-ENT, ENTA-Laryngology / Swallowing / Voice
Bilateral vocal fold paralysis is a difficult condition to manage, with surgical interventions previously limited to tracheostomy or arytenoidectomy. Re-innervation surgery has been developed and, in recent years, a Laryngeal Pacemaker is now in clinical trials. We speak to two...

The Laryngeal Pacemaker – developing an innovative solution for bilateral vocal fold paralysis

4 July 2024 | | ENTA-ENT, ENTA-Laryngology / Swallowing / Voice
Bilateral vocal fold paralysis is a difficult condition to manage, with surgical interventions previously limited to tracheostomy or arytenoidectomy. Re-innervation surgery has been developed and, in recent years, a Laryngeal Pacemaker is now in clinical trials. We speak to two...